CVSA
Covista Inc.
NYSEUSDEQUITY
Consumer Defensive
DELAYED
Buy
+39/100
Last price
127.37
▲ 1.98 (1.58%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
125.40
Prev close
125.39
Day high
127.64
Day low
125.22
Volume
219.62K
Market cap
$4.31B
P/E (TTM)
17.01
52W range
86.97 – 156.26
Day trading desk
Gap from prior close
+0.01%
Prior close 125.39
VWAP
126.90
+0.37% from price
Relative volume
1.05×
Normal
Session range
1.92%
125.21 – 127.62
Position in range
90%
Near session high
ATR (14D)
3.39
2.66% of price
Prior day high
126.79
PDH
Prior day low
124.80
PDL
Bid / ask spread
—
Quote not published
Session volume
374.99K
Avg 357.25K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.63%
+4.7%
1M
-0.56%
-1.7%
3M
-2.66%
-7.2%
6M
+10.81%
-7.4%
YTD
+23.10%
+8.8%
1Y
-14.22%
-30.6%
3Y
+197.25%
+115.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CVSA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+107.78K
Net buying
Buy transactions
7
178.31K shares
Sell transactions
12
70.53K shares
Net transactions
+19
Buys less sells
Sell : buy shares
0.4 : 1
Mixed
Insider-held shares
936.07K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 31, 26 | MALAFRONTE MICHAEL W Director |
STOCK | 2.50K | $0 | Direct |
| Aug 27, 26 | GANGADHARAN MANJUNATH Officer |
SELL | 1.80K | $247.20K | Direct |
| Aug 21, 26 | BEARD STEPHEN W. Chief Executive Officer |
STOCK | 129.06K | $17.08M | Direct |
| Aug 21, 26 | BECK DOUGLAS G General Counsel |
STOCK | 10.30K | $1.36M | Direct |
| Aug 21, 26 | PHELAN, ROBERT JOHN Chief Financial Officer |
STOCK | 17.14K | $2.27M | Direct |
| Aug 21, 26 | GANGADHARAN MANJUNATH Officer |
STOCK | 2.55K | $337.49K | Direct |
| Aug 21, 26 | BETZ MICHAEL Officer |
STOCK | 12.44K | $1.65M | Direct |
| Aug 11, 26 | BEARD STEPHEN W. Chief Executive Officer |
SELL | 3.54K | $462.07K | Direct |
| Aug 7, 26 | BECK DOUGLAS G General Counsel |
SELL | 4.53K | $614.68K | Direct |
| Aug 7, 26 | PHELAN, ROBERT JOHN Chief Financial Officer |
SELL | 2.19K | $295.44K | Direct |
| Jul 13, 26 | BEARD STEPHEN W. Chief Executive Officer |
SELL | 5.29K | $702.40K | Direct |
| Jul 8, 26 | BECK DOUGLAS G General Counsel |
SELL | 5.09K | $688.91K | Direct |
| Jul 8, 26 | PHELAN, ROBERT JOHN Chief Financial Officer |
SELL | 5.31K | $719.50K | Direct |
| Jun 11, 26 | BEARD STEPHEN W. Chief Executive Officer |
SELL | 5.29K | $690.20K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEARD STEPHEN W. |
Chief Executive Officer | 477.46K | Stock Award(Grant) |
BECK DOUGLAS G |
General Counsel | 33.39K | Stock Award(Grant) |
BETZ MICHAEL |
Officer | 39.17K | Stock Award(Grant) |
COX KAREN SUE |
Officer | 31.60K | Sale |
HERRERA MAURICE |
Officer | 20.58K | Stock Award(Grant) |
MALAFRONTE MICHAEL W |
Director | 136.10K | Stock Gift |
PHELAN KENNETH J. |
Director | 19.84K | Stock Award(Grant) |
PHELAN, ROBERT JOHN |
Chief Financial Officer | 56.57K | Stock Award(Grant) |
TRENT EVAN |
Officer | 24.13K | Stock Award(Grant) |
WARDELL LISA W. |
Director | 44.25K | Stock Award(Grant) |
Fundamentals
Market cap$4.31B
Enterprise value$4.83B
Revenue (TTM)$1.95B
Gross profit$1.12B
EBITDA$444.78M
Net income$267.38M
EPS (TTM)$7.49
Free cash flow$323.94M
Total cash$406.32M
Total debt$905.49M
Book value / share$42.49
Shares outstanding33.86M
Float33.14M
Short % of float8.23%
Dividend yield0.00%
Beta (5Y)0.65
Valuation & profitability ratios
Trailing P/E17.01
Forward P/E12.73
PEG ratio0.92
Price / sales—
Price / book3.00
EV / revenue2.47
EV / EBITDA10.87
Gross margin57.34%
Operating margin19.26%
Profit margin12.87%
Return on equity18.57%
Return on assets8.45%
Debt / equity62.61
Current ratio1.09
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.95B | $1.79B | $1.58B | $1.45B | +9.3% |
| Operating revenue | $1.95B | $1.78B | $1.57B | $1.44B | +9.4% |
| Cost of revenue | $833.66M | $771.43M | $698.55M | $648.49M | +8.1% |
| Gross profit | $1.12B | $1.02B | $886.10M | $802.34M | +10.2% |
| Selling, general & admin | $730.72M | $672.00M | $632.97M | $586.01M | +8.7% |
| Total operating expense | $730.72M | $672.00M | $632.97M | $586.01M | +8.7% |
| Operating income | $389.70M | $344.86M | $253.14M | $216.33M | +13.0% |
| Net interest income | -$39.98M | -$44.10M | -$54.48M | -$52.50M | +9.4% |
| Pre-tax income | $345.12M | $298.51M | $163.94M | $112.03M | +15.6% |
| Tax provision | $77.74M | $65.84M | $26.22M | $10.28M | +18.1% |
| Net income | $251.57M | $237.06M | $136.78M | $93.36M | +6.1% |
| Net income to common | $251.57M | $237.06M | $136.78M | $93.36M | +6.1% |
| Basic EPS | 7.18 | 6.39 | 3.47 | 2.08 | +12.4% |
| Diluted EPS | 7.04 | 6.18 | 3.39 | 2.05 | +13.9% |
| EBIT | $384.28M | $342.85M | $218.20M | $170.28M | +12.1% |
| EBITDA | $467.30M | $427.31M | $326.16M | $321.37M | +9.4% |
| Basic shares | 35.05M | 37.09M | 39.41M | 44.78M | -5.5% |
| Diluted shares | 35.72M | 38.33M | 40.31M | 45.60M | -6.8% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $406.32M | $199.60M | $219.31M | $272.19M | +103.6% |
| Cash & short-term investments | $406.32M | $199.60M | $219.31M | $272.19M | +103.6% |
| Accounts receivable | $169.56M | $146.19M | $126.83M | $102.75M | +16.0% |
| Total current assets | $652.44M | $416.19M | $418.08M | $480.30M | +56.8% |
| Property, plant & equipment | $507.01M | $447.32M | $425.28M | $419.33M | +13.3% |
| Goodwill & intangibles | $1.72B | $1.73B | $1.74B | $1.77B | -0.6% |
| Total assets | $3.01B | $2.75B | $2.74B | $2.81B | +9.5% |
| Total current liabilities | $596.82M | $507.93M | $487.66M | $431.20M | +17.5% |
| Current debt | $5.10M | — | — | — | — |
| Long-term debt | $657.75M | $552.67M | $648.71M | $695.08M | +19.0% |
| Total debt | $905.50M | $774.00M | $847.85M | $896.19M | +17.0% |
| Total liabilities | $1.57B | $1.32B | $1.37B | $1.35B | +18.8% |
| Retained earnings | $3.03B | $2.78B | $2.54B | $2.40B | +9.1% |
| Shareholder equity | $1.45B | $1.43B | $1.37B | $1.46B | +0.9% |
| Working capital | $55.62M | -$91.74M | -$69.57M | $49.09M | +160.6% |
| Net tangible assets | -$269.33M | -$293.11M | -$368.82M | -$316.26M | +8.1% |
| Shares issued | 34.03M | 83.94M | 83.19M | 82.23M | -59.5% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $267.38M | $232.68M | $137.71M | $101.75M | +14.9% |
| Depreciation & amortisation | $83.02M | $84.47M | $107.96M | $151.09M | -1.7% |
| Stock-based compensation | $41.22M | $41.59M | $25.95M | $14.30M | -0.9% |
| Change in working capital | -$64.57M | -$114.58M | -$52.91M | -$103.79M | +43.6% |
| Operating cash flow | $470.42M | $337.90M | $295.77M | $191.91M | +39.2% |
| Capital expenditure | -$77.70M | -$50.33M | -$48.89M | -$26.01M | -54.4% |
| Investing cash flow | -$83.70M | -$41.92M | -$47.85M | $23.74M | -99.7% |
| Share buybacks | -$239.87M | -$213.13M | -$261.97M | -$123.13M | -12.5% |
| Financing cash flow | -$180.13M | -$316.02M | -$301.80M | -$288.51M | +43.0% |
| Free cash flow | $392.73M | $287.57M | $246.88M | $165.90M | +36.6% |
| End cash position | $407.75M | $201.16M | $221.20M | $275.07M | +102.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $501.38M | $487.03M | $503.38M | $462.29M | $457.11M | +2.9% |
| Operating revenue | $498.74M | $484.60M | $501.75M | $460.10M | $455.07M | +2.9% |
| Cost of revenue | $216.75M | $210.72M | $205.43M | $200.77M | $198.93M | +2.9% |
| Gross profit | $284.63M | $276.31M | $297.96M | $261.52M | $258.18M | +3.0% |
| Selling, general & admin | $188.09M | $184.11M | $182.79M | $175.73M | $180.86M | +2.2% |
| Total operating expense | $188.09M | $184.11M | $182.79M | $175.73M | $180.86M | +2.2% |
| Operating income | $96.54M | $92.20M | $115.17M | $85.79M | $77.31M | +4.7% |
| Net interest income | -$8.20M | -$13.15M | -$9.34M | -$9.28M | -$9.15M | +37.6% |
| Pre-tax income | $88.40M | $77.94M | $101.90M | $76.87M | $68.58M | +13.4% |
| Tax provision | $16.24M | $19.96M | $25.73M | $15.81M | $14.12M | -18.6% |
| Net income | $71.72M | $41.64M | $76.38M | $61.83M | $54.21M | +72.3% |
| Net income to common | $71.72M | $41.64M | $76.38M | $61.83M | $54.21M | +72.3% |
| Basic EPS | 2.11 | 1.21 | 2.14 | 1.71 | 1.50 | +74.4% |
| Diluted EPS | 2.06 | 1.20 | 2.11 | 1.67 | 1.44 | +71.7% |
| EBIT | $96.72M | $90.03M | $111.52M | $86.39M | $77.88M | +7.4% |
| EBITDA | $117.69M | $110.80M | $132.47M | $106.71M | $98.33M | +6.2% |
| Basic shares | 34.03M | 34.28M | 35.73M | 36.11M | 36.03M | -0.7% |
| Diluted shares | 34.76M | 34.78M | 36.23M | 37.06M | 37.58M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $406.32M | $146.98M | $56.28M | $264.69M | $199.60M | +176.4% |
| Cash & short-term investments | $406.32M | $146.98M | $56.28M | $264.69M | $199.60M | +176.4% |
| Accounts receivable | $169.56M | $175.92M | $162.85M | $194.84M | $146.19M | -3.6% |
| Total current assets | $652.44M | $403.75M | $302.98M | $567.22M | $416.19M | +61.6% |
| Property, plant & equipment | $507.01M | $478.05M | $455.52M | $447.12M | $447.32M | +6.1% |
| Goodwill & intangibles | $1.72B | $1.72B | $1.72B | $1.72B | $1.73B | -0.2% |
| Total assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | +10.1% |
| Total current liabilities | $596.82M | $580.45M | $442.88M | $576.62M | $507.93M | +2.8% |
| Current debt | $5.10M | $3.83M | — | — | — | +33.3% |
| Long-term debt | $657.75M | $495.64M | $504.28M | $553.15M | $552.67M | +32.7% |
| Total debt | $905.50M | $736.29M | $729.55M | $775.95M | $774.00M | +23.0% |
| Total liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | +14.1% |
| Retained earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | +2.4% |
| Shareholder equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | +6.0% |
| Working capital | $55.62M | -$176.69M | -$139.90M | -$9.40M | -$91.74M | +131.5% |
| Net tangible assets | -$269.33M | -$354.22M | -$342.33M | -$266.31M | -$293.11M | +24.0% |
| Shares issued | 34.03M | 84.74M | 84.74M | 84.66M | 83.94M | -59.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $72.16M | $57.98M | $76.17M | $61.06M | $54.46M | +24.5% |
| Depreciation & amortisation | $20.97M | $20.77M | $20.95M | $20.32M | $20.45M | +0.9% |
| Stock-based compensation | $10.11M | $9.57M | $13.24M | $8.29M | $10.41M | +5.7% |
| Change in working capital | -$1.45M | $67.89M | -$102.21M | -$28.81M | -$40.88M | -102.1% |
| Operating cash flow | $123.96M | $186.17M | $29.74M | $130.55M | $59.69M | -33.4% |
| Capital expenditure | -$26.81M | -$20.23M | -$14.62M | -$16.02M | -$18.99M | -32.5% |
| Investing cash flow | -$27.82M | -$20.23M | -$19.62M | -$16.02M | -$11.66M | -37.5% |
| Share buybacks | $0 | -$67.50M | -$164.77M | -$7.59M | -$66.69M | +100.0% |
| Financing cash flow | $162.77M | -$75.73M | -$217.67M | -$49.51M | -$68.05M | +314.9% |
| Free cash flow | $97.15M | $165.93M | $15.12M | $114.53M | $40.70M | -41.5% |
| End cash position | $407.75M | $148.84M | $58.64M | $266.19M | $201.16M | +174.0% |
Options analytics
Put / call volume
2.84
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
90.00
-29.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
57
Contracts, this expiry
Put volume
162
Contracts, this expiry
Heaviest call OI
110.00
0 contracts
Heaviest put OI
90.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.89 | 2.09 | +10.4% |
| Mar 2026 | 1.72 | 1.98 | +15.0% |
| Dec 2025 | 2.19 | 2.43 | +11.1% |
| Sep 2025 | 1.58 | 1.75 | +10.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.83 | 4 | $490.66M | +6.1% |
| Next quarter | 2.40 | 4 | $519.81M | +3.3% |
| Current year | 9.05 | 4 | $2.07B | +6.1% |
| Next year | 10.01 | 4 | $2.22B | +7.2% |
Analyst targets & ownership
Mean target$158.75
High target$175.00
Low target$140.00
Implied upside24.64%
Analyst count4
ConsensusBUY
Strong buy / Buy1 / 2
Hold1
Sell / Strong sell0 / 0
Held by insiders2.75%
Held by institutions103.58%
Institutions holding519
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
122.88
+3.65% from price
SMA 20
124.22
+2.54% from price
SMA 50
128.27
-0.70% from price
SMA 100
126.00
+1.08% from price
SMA 200
117.76
+8.16% from price
EMA 12
124.28
+2.48% from price
EMA 26
125.38
+1.59% from price
EMA 50
126.03
+1.06% from price
RSI (14)
53.9
Neutral
MACD (12,26,9)
-1.10
Hist 0.53
ATR (14)
3.39
2.66% of price
Realised vol 30D
30.2%
Annualised
Bollinger upper
129.36
20, 2σ
Bollinger lower
119.07
20, 2σ
50 / 200 cross
Golden
128.27 vs 117.76
Trend bias
Above 200
+8.16%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.07
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
30.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-42.0%
Peak to trough
Max drawdown 5Y
-49.2%
Peak to trough
ATR 14
3.39
2.66% of price
Beta (reported)
0.65
5Y monthly, from filing
Short interest
Shares short
1.94M
Prior 1.63M
Change vs prior
+18.9%
Shorts adding
% of float
8.23%
Normal
% of shares out
5.69%
Against total outstanding
Days to cover
5.8
Crowded exit
Float
33.14M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Sep 3, 26 | Truist Securities | DOWNGRADE | Buy | Hold |
| Jun 8, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Apr 17, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Mar 24, 26 | Truist Securities | INITIATED | — | Buy |
| Mar 2, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 29, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Oct 31, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Oct 15, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Sep 23, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield0.94%
Payout ratio0.00%
Ex-dividend dateNov 30, 2016
Next pay date—
Last split2:1
Split dateJun 22, 1998
SEC filings
Proxy Statements
DEF 14A · 2026-10-02
Corporate Changes & Voting Matters
8-K · 2026-09-23
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-28
Annual report of employee stock purchase
11-K · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-04-09
Corporate Changes & Voting Matters
8-K · 2026-03-03
Headlines
1 Profitable Stock to Target This Week and 2 We Ignore
StockStory · 21h ago
3 Reasons to Avoid CVSA and 1 Stock to Buy Instead
StockStory · 1d ago
The DAISY Foundation® Names Walden University an Extraordinary Educational Partner
Business Wire · 6d ago
Covista Announces First Quarter Fiscal Year 2027 Conference Call
Business Wire · 8d ago
The Healthcare Workforce Gap Is Set to Nearly Double by 2040
Business Wire · 9d ago
1 Safe-and-Steady Stock on Our Buy List and 2 Facing Challenges
StockStory · 19d ago
The Health Collaborative receives $150,000 investment from Covista, the parent company for Chamberlain University, to Expand Healthcare Career Exploration Opportunities for Greater Cincinnati Students
Business Wire · 22d ago
Chamberlain University Names Jason Dunne Chief Academic Officer
Business Wire · 23d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.